论文部分内容阅读
进入2012年,尽管在国际金融危机与国内经济持续下滑的双重背景下,医药行业却逆势走强,成为资本追逐的一大热点。从行业细分角度上看,医药行业分为中药、化学与生物制药、医疗器械。因此,在该行业投资如此火爆的态势下,如何寻找到最具投资价值的企业成为投资者亟待解决的问题。就此话题,笔者将详细阐述医药细分行业中存在的潜力与投资标的。国粹中药的发展潜力2012年国家相关部门对中医药行业的扶持政策可谓是接连不断。先是在
Into 2012, despite the dual background of the international financial crisis and the continuous downturn of the domestic economy, the pharmaceutical industry has become a hot spot in capital chasing. From the perspective of industry segmentation, the pharmaceutical industry is divided into traditional Chinese medicine, chemical and biological pharmaceuticals, medical devices. Therefore, in the industry so hot investment situation, how to find the most investment value of the business investors become an urgent problem to be solved. On this topic, I will elaborate on the potential of the pharmaceutical industry segments and investment targets. The Development Potential of Chinese Traditional Herbal Medicine In 2012, the relevant state departments in China supported the traditional Chinese medicine industry with a series of policies. First at